Table 2.
Control | Patient | |
---|---|---|
Male gender | 12 (48%) | 30 (60%) |
Hispanic | 16 (64%) | 27 (54%) |
Non-Hispanic White | 5 (20%) | 10 (20%) |
African American | 3 (12%) | 13 (26%) |
Mean age | 41.44 (15.68) | 43.98 (9.43) |
Mean years of education | 13.28 (1.06) | 12.31 (2.44) |
Number employed competitively at least part time | 24 (96%) | 14 (28%)* |
DAR instrumental activity | .93 (.21) | .87 (.24) |
DAR social activity | .80 (.30) | .44 (.29)* |
DAR work/school activity | .78 (.31) | .07 (.14)* |
DAR TOT | 2.51 (.33) | 1.38 (0.45)* |
Hours of sleep per day | 7.97 (1.04) | 11.03 (2.51)* |
Brief cognitive assessment | .45 (.48) | −0.22 (.77)* |
UPSA-B | 72.77 (11.63) | 56.41 (17.79)* |
Social and Occupational Functioning Scale | 78.55 (7.5) | 44.48 (10.26)* |
SOFI (patients only) | 52.11 (14.78) | |
PANSS positive symptom factor mean score (patients only) | 2.51 (.88) | |
PANSS negative symptom factor mean score | 2.19 (.91) | |
NSA-16 mean score | 2.69 (.75) | |
NSA social domain | 2.87 (.99) | |
NSA motivation domain | 3.51 (.82) | |
NSA activity item 14 | 4.62 (.80) | |
Completed calls | 18.32 (2.53) | 17.77 (3.83) |
Note: DAR, daily activity report; SOFI, Schizophrenia Objective Functioning Instrument; PANSS, Positive and Negative Syndrome Scale; NSA, Negative Symptom Assessment.
*P < .0001.